CDHA CAAR

February 12, 2019

CAAR – Lancet Neurology Article Abstracts – February 12, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:17 pm

A. “Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 trial,” by Peter A. LeWitt, Robert A. Hauser, Rajesh Pahwa, Stuart H. Isaacson, Hubert H. Fernandez, Mark Lew, Marie Saint-Hilaire, Emmanuelle Pourcher, Lydia Lopez-Manzanares, Cheryl Waters, Monika Rudzínska, Alexander Sedkov, Richard Batycky, and Charles Oh on behalf of the SPAN-PD Study Investigators (Vol. 18, No. 2, February 2019, p. 145-154).

www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30405-8/fulltext

B. “Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer’s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project,” by Lindsay M. K. Wallace, Olga Theou, Judith Godin, Melissa K. Andrew, David A. Bennett, and Kenneth Rockwood (Vol. 18, No. 2, February 2019, p. 177-184).

www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30371-5/fulltext

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress